Solutions de Diagnostic Biomark inc.

6 enregistrements totalisant 996,050.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.

Intégrer ce graphique

Par ministère

Conseil national de recherches Canada $996,050 6 enregistrements

Enregistrements

National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
EF 2025-2026
Canada

This project integrates multiple parameters into a risk-based model to improve the accuracy of early lung cancer detection and distinguish benign from malignant nodules.

National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
EF 2022-2023
Canada

Development of a safe, effective and affordable drug biomarker test to assess and monitor response to cancer therapy.

National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
EF 2021-2022
Canada

Development of a non-invasive, highly sensitive and accurate molecular test for the early detection and screening of lung cancer

National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
EF 2024-2025
Canada

This feasibility project is aiming to develop a non-invasive blood test that can detect breast cancer at a very early stage, when treatment is most effective.

National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
EF 2022-2023
Canada

The project will fund the development of the firm's intellectual property capacity

National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Youth Employment Program
EF 2023-2024
Canada

Development of a cutting-edge technological platform for early cancer detection.